MicroRNA-142 regulates gut associated lymphoid tissues and group 3 innate lymphoid cells.

ILC3 Innate Lymphoid Cells Intestine Peyer’s Patches miR-142

Journal

Mucosal immunology
ISSN: 1935-3456
Titre abrégé: Mucosal Immunol
Pays: United States
ID NLM: 101299742

Informations de publication

Date de publication:
06 Sep 2024
Historique:
received: 18 09 2023
revised: 26 08 2024
accepted: 02 09 2024
medline: 9 9 2024
pubmed: 9 9 2024
entrez: 8 9 2024
Statut: aheadofprint

Résumé

The transcriptomic signatures that shape responses of innate lymphoid cells (ILCs) have been well characterised, however post-transcriptional mechanisms which regulate their development and activity remain poorly understood. We demonstrate that ILC groups of the intestinal lamina propria express mature forms of microRNA-142 (miR-142), an evolutionarily conserved microRNA family with several non-redundant regulatory roles within the immune system. Germline Mir142 deletion alters intestinal ILC compositions, resulting in the absence of T-bet

Identifiants

pubmed: 39245145
pii: S1933-0219(24)00094-1
doi: 10.1016/j.mucimm.2024.09.001
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Luke B Roberts (LB)

Lydia Becker Institute of Immunology and Inflammation, University of Manchester, M13 9PL, United Kingdom. Electronic address: luke.roberts@manchester.ac.uk.

Joana F Neves (JF)

Centre for Host-Microbiome Interactions, King's College London, Great Maze Pond, London SE1 9RT, United Kingdom.

Dave C H Lee (DCH)

Lydia Becker Institute of Immunology and Inflammation, University of Manchester, M13 9PL, United Kingdom.

Sara Valpione (S)

The Christie NHS Foundation Trust, 550 Wilmslow Road, M20 4BX Manchester; Division of Cancer Sciences, The University of Manchester, Oxford Road, M13 9PL Manchester; Cancer Research UK National Biomarker Centre, Wilmslow Road, M20 4BX Manchester.

Roser Tachó-Piñot (R)

Lydia Becker Institute of Immunology and Inflammation, University of Manchester, M13 9PL, United Kingdom.

Jane K Howard (JK)

School of Cardiovascular and Metabolic Medicine & Sciences, King's College London, Great Maze Pond, London SE1 9RT, United Kingdom.

Matthew R Hepworth (MR)

Lydia Becker Institute of Immunology and Inflammation, University of Manchester, M13 9PL, United Kingdom.

Graham M Lord (GM)

Lydia Becker Institute of Immunology and Inflammation, University of Manchester, M13 9PL, United Kingdom; Centre for Gene Therapy and Regenerative Medicine, School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine, King's College London, United Kingdom. Electronic address: graham.lord@kcl.ac.uk.

Classifications MeSH